Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 AMAG Pharma Appoints CFO | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

AMAG Pharma Appoints CFO

Myles brings more than 20 years of industry experience

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Edward (Ted) Myles has been appointed senior vice president, chief financial officer and treasurer of AMAG. Mr. Myles will be responsible for AMAG’s financial and capital markets activities and will oversee the accounting, tax, corporate finance and investor relations teams. Mr. Myles reports to Frank Thomas, president and chief operating officer of AMAG.
 
“We are pleased to have Ted join us as CFO,” said Mr. Thomas. “Ted is an accomplished executive with a proven track record of financial and operational leadership in the biopharmaceutical industry. His experience in corporate finance, coupled with various roles in accounting and investment banking earlier in his career, make Ted an important addition to the executive leadership team. He will play a critical role in our continued efforts to fund the growth of the company and to create additional shareholder value.”
 
Mr. Myles has more than 20 years of public and private corporate finance and operational experience in the biotechnology, pharmaceutical and medical device industries. Prior to joining the company, he held various positions at Ocata Therapeutics, Inc., most recently as chief financial officer and chief operating officer. Mr. Myles also served as chief financial officer and vice president of operations at PrimeraDx, Inc., senior vice president of finance and chief financial officer of Pressure Biosciences, Inc., and controller at EMD Pharmaceuticals, Inc.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters